2025 proved to be a strong year for Sheridan Capital Partners despite market volatility. We remained focused on disciplined growth and value creation across the portfolio, closing on multiple platform and add-on investments, and realizing two successful exits.

AUBURN, N.Y. – January 20, 2026 – Currier Plastics (“Currier”), a manufacturer of custom, precision plastic components used primarily in healthcare and life sciences, and provider of value‑added services including design engineering, material selection, and assembly, today announced the appointment of Steve Bohnet and John Weber to Currier’s Board of Directors.

CHICAGO, IL – January 13, 2026 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in ICANotes (or “the Company”), a Practice Management (“PM”) and Electronic Health Record (“EHR”) software platform purpose-built for the behavioral health market.

CHICAGO, IL – January 8, 2026 – Sheridan Capital Partners (“Sheridan”) today announced that its portfolio company, (“Currier”), has completed the strategic acquisitions of medical contract manufacturing businesses Springboard Manufacturing (“Springboard”) and MOS Plastics (“MOS”).

AUSTIN, TX – November 14, 2025 – Tarrytown Expocare Pharmacy (“Tarrytown” or “the Company”) announced today that funds managed by global investment firm Carlyle (NASDAQ: CG) have completed the acquisition of the Company from Sheridan Capital Partners (“Sheridan”).

CHICAGO, IL – September 29, 2025 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in Currier Plastics (“Currier” or “the Company”), a manufacturer of custom, precision plastic components used primarily in healthcare and life sciences.

CHICAGO, IL – September 16, 2025 – Sheridan Capital Partners (“Sheridan”) today announced the completion of its investment in National Care Systems (“NCS” or the “Company”), a provider of revenue cycle management (“RCM”) software serving skilled nursing facilities (“SNFs”) and assisted living facilities (“ALFs”) across the United States.

CHICAGO, IL – May 28, 2025 – Sheridan Capital Partners (“Sheridan”) today announced the majority sale of DAS Health Ventures, LLC (“DAS Health” or “the Company”), a provider of healthcare IT and business solutions, to Coalesce Capital. Sheridan initially partnered with DAS Health in 2021 and will retain a minority ownership position following the transaction.